Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1/2 3Phase 1 2Phase 3 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 56Lymphoma, Large B-Cell, Diffuse 55Lymphoma, Follicular 48Lymphoma 47Leukemia, Lymphocytic, Chronic, B-Cell 45Lymphoma, Mantle-Cell 41Lymphoma, B-Cell, Marginal Zone 24Lymphoma, B-Cell 22Waldenstrom Macroglobulinemia 17Hodgkin Disease 16Burkitt Lymphoma 16Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Recurrence 10Lymphoma, Large-Cell, Immunoblastic 9Neoplasms 7Multiple Myeloma 6Myelodysplastic Syndromes 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Lymphoma, Extranodal NK-T-Cell 4Leukemia, Hairy Cell 4Intraocular Lymphoma 4Hematologic Neoplasms 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell 3Lymphoma, Primary Effusion 3Immunoblastic Lymphadenopathy 3

Interventions

fludarabine phosphate 4Cyclophosphamide 4Rituximab 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Filgrastim 3Etoposide 3Cyclosporine 3venetoclax 2Whole-Body Irradiation 2Ifosfamide 2Cord Blood Stem Cell Transplantation 2Carboplatin 2veltuzumab 1pirtobrutinib 1pevonedistat 1ocaratuzumab 1iratumumab 1fludarabine 1etoposide phosphate 1aldesleukin 1Vincristine 1Tacrolimus 1Sirolimus 1Psychiatric Rehabilitation 1Prednisone 1Microarray Analysis 1Methotrexate 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Dendritic Cell Sarcoma, Interdigitating × Rituximab × Clear all
NCT03740529 2026-01-27

A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Eli Lilly and Company

Phase 1/2 Completed
803 enrolled 2 FDA
LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT03064867 2022-11-16

Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Case Comprehensive Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡